News

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 20 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2026.

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.0.50 per share (i.e.5%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live News

Remus Pharmaceuticals announced that the 10th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News